Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.


Opinion for Abbott Labs (ABT-N)

Signal Price Bias Subject Owned

They are going to split off their medical device and their pharmaceutical division. This is in kind of a Hold mode right now until the split comes through. This is a company that has raised its dividend historically. Free cash flow is a very good. When the split comes, hang on to both shares. You’ll probably see your average cost base cut in half.

David Driscoll
President & CEO, Liberty International Investment Management Inc

No Comments.

You must be logged in to comment.